1LQB - JenaLib

Asymmetric Unit (120, 120)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
001	UniProt	VAR_034987	L	63	P	VHL_HUMAN	Disease (PCC)	104893827	C	L	63	P
002	UniProt	VAR_034988	R	64	P	VHL_HUMAN	Disease (PCC)	104893826	C	R	64	P
003	UniProt	VAR_034989	S	65	A	VHL_HUMAN	Disease (PCC)	869025616	C	S	65	A
004	UniProt	VAR_005672	S	65	L	VHL_HUMAN	Disease (VHLD)	5030826	C	S	65	L
005	UniProt	VAR_005673	S	65	W	VHL_HUMAN	Disease (VHLD)	5030826	C	S	65	W
006	UniProt	VAR_005675	S	68	W	VHL_HUMAN	Disease (VHLD)	---	C	S	68	W
007	UniProt	VAR_005676	E	70	K	VHL_HUMAN	Disease (VHLD)	5030802	C	E	70	K
008	UniProt	VAR_005677	V	74	G	VHL_HUMAN	Disease (VHLD)	5030803	C	V	74	G
009	UniProt	VAR_005679	F	76	I	VHL_HUMAN	Disease (VHLD)	---	C	F	76	I
010	UniProt	VAR_005680	F	76	L	VHL_HUMAN	Disease (VHLD)	---	C	F	76	L
011	UniProt	VAR_005681	F	76	S	VHL_HUMAN	Disease (VHLD)	730882033	C	F	76	S
012	UniProt	VAR_005682	N	78	H	VHL_HUMAN	Disease (VHLD)	---	C	N	78	H
013	UniProt	VAR_005683	N	78	S	VHL_HUMAN	Disease (VHLD)	5030804	C	N	78	S
014	UniProt	VAR_005684	N	78	T	VHL_HUMAN	Disease (VHLD)	---	C	N	78	T
015	UniProt	VAR_005685	R	79	P	VHL_HUMAN	Disease (VHLD)	---	C	R	79	P
016	UniProt	VAR_005686	S	80	I	VHL_HUMAN	Disease (VHLD)	5030805	C	S	80	I
017	UniProt	VAR_005688	S	80	N	VHL_HUMAN	Disease (VHLD)	5030805	C	S	80	N
018	UniProt	VAR_005687	S	80	R	VHL_HUMAN	Disease (VHLD)	---	C	S	80	R
019	UniProt	VAR_005689	P	81	S	VHL_HUMAN	Disease (VHLD)	5030806	C	P	81	S
020	UniProt	VAR_005690	R	82	P	VHL_HUMAN	Disease (VHLD)	794726890	C	R	82	P
021	UniProt	VAR_005692	V	84	L	VHL_HUMAN	Disease (VHLD)	5030827	C	V	84	L
022	UniProt	VAR_005693	P	86	A	VHL_HUMAN	Disease (VHLD)	398123481	C	P	86	A
023	UniProt	VAR_008097	P	86	H	VHL_HUMAN	Disease (VHLD)	---	C	P	86	H
024	UniProt	VAR_005694	P	86	L	VHL_HUMAN	Disease (VHLD)	730882034	C	P	86	L
025	UniProt	VAR_005695	P	86	R	VHL_HUMAN	Disease (VHLD)	---	C	P	86	R
026	UniProt	VAR_005696	P	86	S	VHL_HUMAN	Disease (VHLD)	398123481	C	P	86	S
027	UniProt	VAR_005697	W	88	R	VHL_HUMAN	Disease (VHLD)	---	C	W	88	R
028	UniProt	VAR_005698	W	88	S	VHL_HUMAN	Disease (VHLD)	119103277	C	W	88	S
029	UniProt	VAR_005699	L	89	H	VHL_HUMAN	Unclassified	5030807	C	L	89	H
030	UniProt	VAR_005700	L	89	P	VHL_HUMAN	Disease (VHLD)	5030807	C	L	89	P
031	UniProt	VAR_005701	F	91	L	VHL_HUMAN	Unclassified	---	C	F	91	L
032	UniProt	VAR_005703	G	93	C	VHL_HUMAN	Disease (VHLD)	5030808	C	G	93	C
033	UniProt	VAR_005704	G	93	D	VHL_HUMAN	Disease (VHLD)	---	C	G	93	D
034	UniProt	VAR_005705	G	93	S	VHL_HUMAN	Disease (VHLD)	5030808	C	G	93	S
035	UniProt	VAR_005706	Q	96	P	VHL_HUMAN	Disease (VHLD)	---	C	Q	96	P
036	UniProt	VAR_005707	Y	98	H	VHL_HUMAN	Disease (VHLD)	5030809	C	Y	98	H
037	UniProt	VAR_005708	L	101	G	VHL_HUMAN	Disease (VHLD)	---	C	L	101	G
038	UniProt	VAR_005709	L	101	R	VHL_HUMAN	Disease (VHLD)	---	C	L	101	R
039	UniProt	VAR_005710	G	104	A	VHL_HUMAN	Unclassified	---	C	G	104	A
040	UniProt	VAR_005711	T	105	P	VHL_HUMAN	Disease (VHLD)	---	C	T	105	P
041	UniProt	VAR_005712	G	106	D	VHL_HUMAN	Unclassified	---	C	G	106	D
042	UniProt	VAR_034991	R	107	G	VHL_HUMAN	Disease (PCC)	397516440	C	R	107	G
043	UniProt	VAR_005713	R	107	P	VHL_HUMAN	Disease (VHLD)	193922609	C	R	107	P
044	UniProt	VAR_055087	H	110	Y	VHL_HUMAN	Polymorphism	17855706	C	H	110	Y
045	UniProt	VAR_005714	S	111	C	VHL_HUMAN	Disease (VHLD)	---	C	S	111	C
046	UniProt	VAR_005715	S	111	N	VHL_HUMAN	Disease (VHLD)	869025631	C	S	111	N
047	UniProt	VAR_005716	S	111	R	VHL_HUMAN	Disease (VHLD)	765978945	C	S	111	R
048	UniProt	VAR_005717	Y	112	H	VHL_HUMAN	Disease (VHLD)	104893824	C	Y	112	H
049	UniProt	VAR_034992	Y	112	N	VHL_HUMAN	Disease (VHLD)	104893824	C	Y	112	N
050	UniProt	VAR_005718	G	114	C	VHL_HUMAN	Disease (VHLD)	---	C	G	114	C
051	UniProt	VAR_005719	G	114	R	VHL_HUMAN	Disease (VHLD)	869025636	C	G	114	R
052	UniProt	VAR_005720	G	114	S	VHL_HUMAN	Disease (VHLD)	---	C	G	114	S
053	UniProt	VAR_005723	H	115	Q	VHL_HUMAN	Disease (VHLD)	---	C	H	115	Q
054	UniProt	VAR_008098	H	115	R	VHL_HUMAN	Disease (VHLD)	5030812	C	H	115	R
055	UniProt	VAR_005722	H	115	Y	VHL_HUMAN	Disease (VHLD)	5030811	C	H	115	Y
056	UniProt	VAR_005724	L	116	V	VHL_HUMAN	Disease (VHLD)	---	C	L	116	V
057	UniProt	VAR_005725	W	117	C	VHL_HUMAN	Disease (VHLD)	727504215	C	W	117	C
058	UniProt	VAR_005726	L	118	P	VHL_HUMAN	Disease (VHLD)	5030830	C	L	118	P
059	UniProt	VAR_005727	L	118	R	VHL_HUMAN	Disease (VHLD)	---	C	L	118	R
060	UniProt	VAR_005728	F	119	L	VHL_HUMAN	Disease (VHLD)	---	C	F	119	L
061	UniProt	VAR_005729	F	119	S	VHL_HUMAN	Disease (VHLD)	---	C	F	119	S
062	UniProt	VAR_005730	D	121	G	VHL_HUMAN	Disease (VHLD)	5030832	C	D	121	G
063	UniProt	VAR_034993	A	122	I	VHL_HUMAN	Disease (PCC)	---	C	A	122	I
064	UniProt	VAR_034994	D	126	Y	VHL_HUMAN	Disease (ECYT2)	104893831	C	D	126	Y
065	UniProt	VAR_005731	L	128	F	VHL_HUMAN	Disease (VHLD)	---	C	L	128	F
066	UniProt	VAR_005733	V	130	L	VHL_HUMAN	Disease (VHLD)	104893830	C	V	130	L
067	UniProt	VAR_005734	N	131	K	VHL_HUMAN	Disease (VHLD)	---	C	N	131	K
068	UniProt	VAR_005735	N	131	T	VHL_HUMAN	Disease (VHLD)	---	C	N	131	T
069	UniProt	VAR_034995	L	135	F	VHL_HUMAN	Polymorphism	119103278	C	L	135	F
070	UniProt	VAR_005737	F	136	C	VHL_HUMAN	Disease (VHLD)	5030833	C	F	136	C
071	UniProt	VAR_005736	F	136	S	VHL_HUMAN	Disease (VHLD)	5030833	C	F	136	S
072	UniProt	VAR_008099	F	136	Y	VHL_HUMAN	Disease (VHLD)	---	C	F	136	Y
073	UniProt	VAR_005738	D	143	E	VHL_HUMAN	Disease (VHLD)	---	C	D	143	E
074	UniProt	VAR_008100	Q	145	H	VHL_HUMAN	Disease (VHLD)	771727849	C	Q	145	H
075	UniProt	VAR_034996	I	147	T	VHL_HUMAN	Disease (PCC)	---	C	I	147	T
076	UniProt	VAR_005740	A	149	T	VHL_HUMAN	Disease (VHLD)	587780077	C	A	149	T
077	UniProt	VAR_005741	P	154	L	VHL_HUMAN	Disease (VHLD)	---	C	P	154	L
078	UniProt	VAR_005742	V	155	G	VHL_HUMAN	Disease (VHLD)	---	C	V	155	G
079	UniProt	VAR_008101	V	155	M	VHL_HUMAN	Disease (VHLD)	869025659	C	V	155	M
080	UniProt	VAR_005743	Y	156	C	VHL_HUMAN	Disease (VHLD)	397516441	C	Y	156	C
081	UniProt	VAR_005744	Y	156	D	VHL_HUMAN	Disease (VHLD)	---	C	Y	156	D
082	UniProt	VAR_034997	Y	156	N	VHL_HUMAN	Disease (PCC)	---	C	Y	156	N
083	UniProt	VAR_005746	T	157	I	VHL_HUMAN	Disease (VHLD)	869025660	C	T	157	I
084	UniProt	VAR_005748	L	158	P	VHL_HUMAN	Disease (VHLD)	121913346	C	L	158	P
085	UniProt	VAR_005749	L	158	V	VHL_HUMAN	Disease (VHLD)	---	C	L	158	V
086	UniProt	VAR_005750	K	159	E	VHL_HUMAN	Disease (VHLD)	---	C	K	159	E
087	UniProt	VAR_005753	R	161	G	VHL_HUMAN	Disease (VHLD)	5030818	C	R	161	G
088	UniProt	VAR_005752	R	161	P	VHL_HUMAN	Disease (VHLD)	---	C	R	161	P
089	UniProt	VAR_005751	R	161	Q	VHL_HUMAN	Disease (VHLD)	730882035	C	R	161	Q
090	UniProt	VAR_005754	C	162	F	VHL_HUMAN	Disease (VHLD)	397516444	C	C	162	F
091	UniProt	VAR_005755	C	162	R	VHL_HUMAN	Disease (VHLD)	---	C	C	162	R
092	UniProt	VAR_005756	C	162	W	VHL_HUMAN	Disease (VHLD)	5030622	C	C	162	W
093	UniProt	VAR_005757	C	162	Y	VHL_HUMAN	Disease (VHLD)	---	C	C	162	Y
094	UniProt	VAR_034998	L	163	P	VHL_HUMAN	Disease (RCC)	28940297	C	L	163	P
095	UniProt	VAR_008102	Q	164	H	VHL_HUMAN	Disease (VHLD)	---	C	Q	164	H
096	UniProt	VAR_005758	Q	164	R	VHL_HUMAN	Disease (VHLD)	267607170	C	Q	164	R
097	UniProt	VAR_008103	V	166	D	VHL_HUMAN	Disease (VHLD)	---	C	V	166	D
098	UniProt	VAR_005759	V	166	F	VHL_HUMAN	Disease (VHLD)	104893825	C	V	166	F
099	UniProt	VAR_005760	R	167	G	VHL_HUMAN	Disease (VHLD)	5030820	C	R	167	G
100	UniProt	VAR_005761	R	167	Q	VHL_HUMAN	Disease (VHLD)	5030821	C	R	167	Q
101	UniProt	VAR_005762	R	167	W	VHL_HUMAN	Disease (VHLD)	5030820	C	R	167	W
102	UniProt	VAR_005763	V	170	D	VHL_HUMAN	Disease (VHLD)	---	C	V	170	D
103	UniProt	VAR_005764	V	170	F	VHL_HUMAN	Disease (VHLD)	---	C	V	170	F
104	UniProt	VAR_005765	V	170	G	VHL_HUMAN	Disease (VHLD)	---	C	V	170	G
105	UniProt	VAR_005766	Y	175	D	VHL_HUMAN	Disease (VHLD)	---	C	Y	175	D
106	UniProt	VAR_008104	R	176	W	VHL_HUMAN	Disease (VHLD)	---	C	R	176	W
107	UniProt	VAR_005768	L	178	P	VHL_HUMAN	Disease (VHLD)	---	C	L	178	P
108	UniProt	VAR_005769	L	178	Q	VHL_HUMAN	Disease (VHLD)	5030822	C	L	178	Q
109	UniProt	VAR_005770	I	180	V	VHL_HUMAN	Disease (VHLD)	377715747	C	I	180	V
110	UniProt	VAR_005772	L	184	P	VHL_HUMAN	Disease (VHLD)	---	C	L	184	P
111	UniProt	VAR_005771	L	184	R	VHL_HUMAN	Disease (VHLD)	---	C	L	184	R
112	UniProt	VAR_005773	E	186	K	VHL_HUMAN	Disease (VHLD)	367545984	C	E	186	K
113	UniProt	VAR_005775	L	188	P	VHL_HUMAN	Disease (VHLD)	---	C	L	188	P
114	UniProt	VAR_005776	L	188	Q	VHL_HUMAN	Disease (VHLD)	---	C	L	188	Q
115	UniProt	VAR_005777	L	188	V	VHL_HUMAN	Disease (VHLD)	5030824	C	L	188	V
116	UniProt	VAR_034999	H	191	D	VHL_HUMAN	Disease (ECYT2)	28940301	C	H	191	D
117	UniProt	VAR_035000	P	192	S	VHL_HUMAN	Disease (ECYT2)	28940300	C	P	192	S
118	UniProt	VAR_035001	L	198	Q	VHL_HUMAN	Disease (PCC)	---	C	L	198	Q
119	UniProt	VAR_005778	L	198	R	VHL_HUMAN	Disease (VHLD)	---	C	L	198	R
120	UniProt	VAR_005779	R	200	W	VHL_HUMAN	Disease (VHLD)	28940298	C	R	200	W

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (120, 120)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
001	UniProt	VAR_034987	L	63	P	VHL_HUMAN	Disease (PCC)	104893827	C	L	63	P
002	UniProt	VAR_034988	R	64	P	VHL_HUMAN	Disease (PCC)	104893826	C	R	64	P
003	UniProt	VAR_034989	S	65	A	VHL_HUMAN	Disease (PCC)	869025616	C	S	65	A
004	UniProt	VAR_005672	S	65	L	VHL_HUMAN	Disease (VHLD)	5030826	C	S	65	L
005	UniProt	VAR_005673	S	65	W	VHL_HUMAN	Disease (VHLD)	5030826	C	S	65	W
006	UniProt	VAR_005675	S	68	W	VHL_HUMAN	Disease (VHLD)	---	C	S	68	W
007	UniProt	VAR_005676	E	70	K	VHL_HUMAN	Disease (VHLD)	5030802	C	E	70	K
008	UniProt	VAR_005677	V	74	G	VHL_HUMAN	Disease (VHLD)	5030803	C	V	74	G
009	UniProt	VAR_005679	F	76	I	VHL_HUMAN	Disease (VHLD)	---	C	F	76	I
010	UniProt	VAR_005680	F	76	L	VHL_HUMAN	Disease (VHLD)	---	C	F	76	L
011	UniProt	VAR_005681	F	76	S	VHL_HUMAN	Disease (VHLD)	730882033	C	F	76	S
012	UniProt	VAR_005682	N	78	H	VHL_HUMAN	Disease (VHLD)	---	C	N	78	H
013	UniProt	VAR_005683	N	78	S	VHL_HUMAN	Disease (VHLD)	5030804	C	N	78	S
014	UniProt	VAR_005684	N	78	T	VHL_HUMAN	Disease (VHLD)	---	C	N	78	T
015	UniProt	VAR_005685	R	79	P	VHL_HUMAN	Disease (VHLD)	---	C	R	79	P
016	UniProt	VAR_005686	S	80	I	VHL_HUMAN	Disease (VHLD)	5030805	C	S	80	I
017	UniProt	VAR_005688	S	80	N	VHL_HUMAN	Disease (VHLD)	5030805	C	S	80	N
018	UniProt	VAR_005687	S	80	R	VHL_HUMAN	Disease (VHLD)	---	C	S	80	R
019	UniProt	VAR_005689	P	81	S	VHL_HUMAN	Disease (VHLD)	5030806	C	P	81	S
020	UniProt	VAR_005690	R	82	P	VHL_HUMAN	Disease (VHLD)	794726890	C	R	82	P
021	UniProt	VAR_005692	V	84	L	VHL_HUMAN	Disease (VHLD)	5030827	C	V	84	L
022	UniProt	VAR_005693	P	86	A	VHL_HUMAN	Disease (VHLD)	398123481	C	P	86	A
023	UniProt	VAR_008097	P	86	H	VHL_HUMAN	Disease (VHLD)	---	C	P	86	H
024	UniProt	VAR_005694	P	86	L	VHL_HUMAN	Disease (VHLD)	730882034	C	P	86	L
025	UniProt	VAR_005695	P	86	R	VHL_HUMAN	Disease (VHLD)	---	C	P	86	R
026	UniProt	VAR_005696	P	86	S	VHL_HUMAN	Disease (VHLD)	398123481	C	P	86	S
027	UniProt	VAR_005697	W	88	R	VHL_HUMAN	Disease (VHLD)	---	C	W	88	R
028	UniProt	VAR_005698	W	88	S	VHL_HUMAN	Disease (VHLD)	119103277	C	W	88	S
029	UniProt	VAR_005699	L	89	H	VHL_HUMAN	Unclassified	5030807	C	L	89	H
030	UniProt	VAR_005700	L	89	P	VHL_HUMAN	Disease (VHLD)	5030807	C	L	89	P
031	UniProt	VAR_005701	F	91	L	VHL_HUMAN	Unclassified	---	C	F	91	L
032	UniProt	VAR_005703	G	93	C	VHL_HUMAN	Disease (VHLD)	5030808	C	G	93	C
033	UniProt	VAR_005704	G	93	D	VHL_HUMAN	Disease (VHLD)	---	C	G	93	D
034	UniProt	VAR_005705	G	93	S	VHL_HUMAN	Disease (VHLD)	5030808	C	G	93	S
035	UniProt	VAR_005706	Q	96	P	VHL_HUMAN	Disease (VHLD)	---	C	Q	96	P
036	UniProt	VAR_005707	Y	98	H	VHL_HUMAN	Disease (VHLD)	5030809	C	Y	98	H
037	UniProt	VAR_005708	L	101	G	VHL_HUMAN	Disease (VHLD)	---	C	L	101	G
038	UniProt	VAR_005709	L	101	R	VHL_HUMAN	Disease (VHLD)	---	C	L	101	R
039	UniProt	VAR_005710	G	104	A	VHL_HUMAN	Unclassified	---	C	G	104	A
040	UniProt	VAR_005711	T	105	P	VHL_HUMAN	Disease (VHLD)	---	C	T	105	P
041	UniProt	VAR_005712	G	106	D	VHL_HUMAN	Unclassified	---	C	G	106	D
042	UniProt	VAR_034991	R	107	G	VHL_HUMAN	Disease (PCC)	397516440	C	R	107	G
043	UniProt	VAR_005713	R	107	P	VHL_HUMAN	Disease (VHLD)	193922609	C	R	107	P
044	UniProt	VAR_055087	H	110	Y	VHL_HUMAN	Polymorphism	17855706	C	H	110	Y
045	UniProt	VAR_005714	S	111	C	VHL_HUMAN	Disease (VHLD)	---	C	S	111	C
046	UniProt	VAR_005715	S	111	N	VHL_HUMAN	Disease (VHLD)	869025631	C	S	111	N
047	UniProt	VAR_005716	S	111	R	VHL_HUMAN	Disease (VHLD)	765978945	C	S	111	R
048	UniProt	VAR_005717	Y	112	H	VHL_HUMAN	Disease (VHLD)	104893824	C	Y	112	H
049	UniProt	VAR_034992	Y	112	N	VHL_HUMAN	Disease (VHLD)	104893824	C	Y	112	N
050	UniProt	VAR_005718	G	114	C	VHL_HUMAN	Disease (VHLD)	---	C	G	114	C
051	UniProt	VAR_005719	G	114	R	VHL_HUMAN	Disease (VHLD)	869025636	C	G	114	R
052	UniProt	VAR_005720	G	114	S	VHL_HUMAN	Disease (VHLD)	---	C	G	114	S
053	UniProt	VAR_005723	H	115	Q	VHL_HUMAN	Disease (VHLD)	---	C	H	115	Q
054	UniProt	VAR_008098	H	115	R	VHL_HUMAN	Disease (VHLD)	5030812	C	H	115	R
055	UniProt	VAR_005722	H	115	Y	VHL_HUMAN	Disease (VHLD)	5030811	C	H	115	Y
056	UniProt	VAR_005724	L	116	V	VHL_HUMAN	Disease (VHLD)	---	C	L	116	V
057	UniProt	VAR_005725	W	117	C	VHL_HUMAN	Disease (VHLD)	727504215	C	W	117	C
058	UniProt	VAR_005726	L	118	P	VHL_HUMAN	Disease (VHLD)	5030830	C	L	118	P
059	UniProt	VAR_005727	L	118	R	VHL_HUMAN	Disease (VHLD)	---	C	L	118	R
060	UniProt	VAR_005728	F	119	L	VHL_HUMAN	Disease (VHLD)	---	C	F	119	L
061	UniProt	VAR_005729	F	119	S	VHL_HUMAN	Disease (VHLD)	---	C	F	119	S
062	UniProt	VAR_005730	D	121	G	VHL_HUMAN	Disease (VHLD)	5030832	C	D	121	G
063	UniProt	VAR_034993	A	122	I	VHL_HUMAN	Disease (PCC)	---	C	A	122	I
064	UniProt	VAR_034994	D	126	Y	VHL_HUMAN	Disease (ECYT2)	104893831	C	D	126	Y
065	UniProt	VAR_005731	L	128	F	VHL_HUMAN	Disease (VHLD)	---	C	L	128	F
066	UniProt	VAR_005733	V	130	L	VHL_HUMAN	Disease (VHLD)	104893830	C	V	130	L
067	UniProt	VAR_005734	N	131	K	VHL_HUMAN	Disease (VHLD)	---	C	N	131	K
068	UniProt	VAR_005735	N	131	T	VHL_HUMAN	Disease (VHLD)	---	C	N	131	T
069	UniProt	VAR_034995	L	135	F	VHL_HUMAN	Polymorphism	119103278	C	L	135	F
070	UniProt	VAR_005737	F	136	C	VHL_HUMAN	Disease (VHLD)	5030833	C	F	136	C
071	UniProt	VAR_005736	F	136	S	VHL_HUMAN	Disease (VHLD)	5030833	C	F	136	S
072	UniProt	VAR_008099	F	136	Y	VHL_HUMAN	Disease (VHLD)	---	C	F	136	Y
073	UniProt	VAR_005738	D	143	E	VHL_HUMAN	Disease (VHLD)	---	C	D	143	E
074	UniProt	VAR_008100	Q	145	H	VHL_HUMAN	Disease (VHLD)	771727849	C	Q	145	H
075	UniProt	VAR_034996	I	147	T	VHL_HUMAN	Disease (PCC)	---	C	I	147	T
076	UniProt	VAR_005740	A	149	T	VHL_HUMAN	Disease (VHLD)	587780077	C	A	149	T
077	UniProt	VAR_005741	P	154	L	VHL_HUMAN	Disease (VHLD)	---	C	P	154	L
078	UniProt	VAR_005742	V	155	G	VHL_HUMAN	Disease (VHLD)	---	C	V	155	G
079	UniProt	VAR_008101	V	155	M	VHL_HUMAN	Disease (VHLD)	869025659	C	V	155	M
080	UniProt	VAR_005743	Y	156	C	VHL_HUMAN	Disease (VHLD)	397516441	C	Y	156	C
081	UniProt	VAR_005744	Y	156	D	VHL_HUMAN	Disease (VHLD)	---	C	Y	156	D
082	UniProt	VAR_034997	Y	156	N	VHL_HUMAN	Disease (PCC)	---	C	Y	156	N
083	UniProt	VAR_005746	T	157	I	VHL_HUMAN	Disease (VHLD)	869025660	C	T	157	I
084	UniProt	VAR_005748	L	158	P	VHL_HUMAN	Disease (VHLD)	121913346	C	L	158	P
085	UniProt	VAR_005749	L	158	V	VHL_HUMAN	Disease (VHLD)	---	C	L	158	V
086	UniProt	VAR_005750	K	159	E	VHL_HUMAN	Disease (VHLD)	---	C	K	159	E
087	UniProt	VAR_005753	R	161	G	VHL_HUMAN	Disease (VHLD)	5030818	C	R	161	G
088	UniProt	VAR_005752	R	161	P	VHL_HUMAN	Disease (VHLD)	---	C	R	161	P
089	UniProt	VAR_005751	R	161	Q	VHL_HUMAN	Disease (VHLD)	730882035	C	R	161	Q
090	UniProt	VAR_005754	C	162	F	VHL_HUMAN	Disease (VHLD)	397516444	C	C	162	F
091	UniProt	VAR_005755	C	162	R	VHL_HUMAN	Disease (VHLD)	---	C	C	162	R
092	UniProt	VAR_005756	C	162	W	VHL_HUMAN	Disease (VHLD)	5030622	C	C	162	W
093	UniProt	VAR_005757	C	162	Y	VHL_HUMAN	Disease (VHLD)	---	C	C	162	Y
094	UniProt	VAR_034998	L	163	P	VHL_HUMAN	Disease (RCC)	28940297	C	L	163	P
095	UniProt	VAR_008102	Q	164	H	VHL_HUMAN	Disease (VHLD)	---	C	Q	164	H
096	UniProt	VAR_005758	Q	164	R	VHL_HUMAN	Disease (VHLD)	267607170	C	Q	164	R
097	UniProt	VAR_008103	V	166	D	VHL_HUMAN	Disease (VHLD)	---	C	V	166	D
098	UniProt	VAR_005759	V	166	F	VHL_HUMAN	Disease (VHLD)	104893825	C	V	166	F
099	UniProt	VAR_005760	R	167	G	VHL_HUMAN	Disease (VHLD)	5030820	C	R	167	G
100	UniProt	VAR_005761	R	167	Q	VHL_HUMAN	Disease (VHLD)	5030821	C	R	167	Q
101	UniProt	VAR_005762	R	167	W	VHL_HUMAN	Disease (VHLD)	5030820	C	R	167	W
102	UniProt	VAR_005763	V	170	D	VHL_HUMAN	Disease (VHLD)	---	C	V	170	D
103	UniProt	VAR_005764	V	170	F	VHL_HUMAN	Disease (VHLD)	---	C	V	170	F
104	UniProt	VAR_005765	V	170	G	VHL_HUMAN	Disease (VHLD)	---	C	V	170	G
105	UniProt	VAR_005766	Y	175	D	VHL_HUMAN	Disease (VHLD)	---	C	Y	175	D
106	UniProt	VAR_008104	R	176	W	VHL_HUMAN	Disease (VHLD)	---	C	R	176	W
107	UniProt	VAR_005768	L	178	P	VHL_HUMAN	Disease (VHLD)	---	C	L	178	P
108	UniProt	VAR_005769	L	178	Q	VHL_HUMAN	Disease (VHLD)	5030822	C	L	178	Q
109	UniProt	VAR_005770	I	180	V	VHL_HUMAN	Disease (VHLD)	377715747	C	I	180	V
110	UniProt	VAR_005772	L	184	P	VHL_HUMAN	Disease (VHLD)	---	C	L	184	P
111	UniProt	VAR_005771	L	184	R	VHL_HUMAN	Disease (VHLD)	---	C	L	184	R
112	UniProt	VAR_005773	E	186	K	VHL_HUMAN	Disease (VHLD)	367545984	C	E	186	K
113	UniProt	VAR_005775	L	188	P	VHL_HUMAN	Disease (VHLD)	---	C	L	188	P
114	UniProt	VAR_005776	L	188	Q	VHL_HUMAN	Disease (VHLD)	---	C	L	188	Q
115	UniProt	VAR_005777	L	188	V	VHL_HUMAN	Disease (VHLD)	5030824	C	L	188	V
116	UniProt	VAR_034999	H	191	D	VHL_HUMAN	Disease (ECYT2)	28940301	C	H	191	D
117	UniProt	VAR_035000	P	192	S	VHL_HUMAN	Disease (ECYT2)	28940300	C	P	192	S
118	UniProt	VAR_035001	L	198	Q	VHL_HUMAN	Disease (PCC)	---	C	L	198	Q
119	UniProt	VAR_005778	L	198	R	VHL_HUMAN	Disease (VHLD)	---	C	L	198	R
120	UniProt	VAR_005779	R	200	W	VHL_HUMAN	Disease (VHLD)	28940298	C	R	200	W

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (120, 240)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
001	UniProt	VAR_034987	L	63	P	VHL_HUMAN	Disease (PCC)	104893827	C	L	63	P
002	UniProt	VAR_034988	R	64	P	VHL_HUMAN	Disease (PCC)	104893826	C	R	64	P
003	UniProt	VAR_034989	S	65	A	VHL_HUMAN	Disease (PCC)	869025616	C	S	65	A
004	UniProt	VAR_005672	S	65	L	VHL_HUMAN	Disease (VHLD)	5030826	C	S	65	L
005	UniProt	VAR_005673	S	65	W	VHL_HUMAN	Disease (VHLD)	5030826	C	S	65	W
006	UniProt	VAR_005675	S	68	W	VHL_HUMAN	Disease (VHLD)	---	C	S	68	W
007	UniProt	VAR_005676	E	70	K	VHL_HUMAN	Disease (VHLD)	5030802	C	E	70	K
008	UniProt	VAR_005677	V	74	G	VHL_HUMAN	Disease (VHLD)	5030803	C	V	74	G
009	UniProt	VAR_005679	F	76	I	VHL_HUMAN	Disease (VHLD)	---	C	F	76	I
010	UniProt	VAR_005680	F	76	L	VHL_HUMAN	Disease (VHLD)	---	C	F	76	L
011	UniProt	VAR_005681	F	76	S	VHL_HUMAN	Disease (VHLD)	730882033	C	F	76	S
012	UniProt	VAR_005682	N	78	H	VHL_HUMAN	Disease (VHLD)	---	C	N	78	H
013	UniProt	VAR_005683	N	78	S	VHL_HUMAN	Disease (VHLD)	5030804	C	N	78	S
014	UniProt	VAR_005684	N	78	T	VHL_HUMAN	Disease (VHLD)	---	C	N	78	T
015	UniProt	VAR_005685	R	79	P	VHL_HUMAN	Disease (VHLD)	---	C	R	79	P
016	UniProt	VAR_005686	S	80	I	VHL_HUMAN	Disease (VHLD)	5030805	C	S	80	I
017	UniProt	VAR_005688	S	80	N	VHL_HUMAN	Disease (VHLD)	5030805	C	S	80	N
018	UniProt	VAR_005687	S	80	R	VHL_HUMAN	Disease (VHLD)	---	C	S	80	R
019	UniProt	VAR_005689	P	81	S	VHL_HUMAN	Disease (VHLD)	5030806	C	P	81	S
020	UniProt	VAR_005690	R	82	P	VHL_HUMAN	Disease (VHLD)	794726890	C	R	82	P
021	UniProt	VAR_005692	V	84	L	VHL_HUMAN	Disease (VHLD)	5030827	C	V	84	L
022	UniProt	VAR_005693	P	86	A	VHL_HUMAN	Disease (VHLD)	398123481	C	P	86	A
023	UniProt	VAR_008097	P	86	H	VHL_HUMAN	Disease (VHLD)	---	C	P	86	H
024	UniProt	VAR_005694	P	86	L	VHL_HUMAN	Disease (VHLD)	730882034	C	P	86	L
025	UniProt	VAR_005695	P	86	R	VHL_HUMAN	Disease (VHLD)	---	C	P	86	R
026	UniProt	VAR_005696	P	86	S	VHL_HUMAN	Disease (VHLD)	398123481	C	P	86	S
027	UniProt	VAR_005697	W	88	R	VHL_HUMAN	Disease (VHLD)	---	C	W	88	R
028	UniProt	VAR_005698	W	88	S	VHL_HUMAN	Disease (VHLD)	119103277	C	W	88	S
029	UniProt	VAR_005699	L	89	H	VHL_HUMAN	Unclassified	5030807	C	L	89	H
030	UniProt	VAR_005700	L	89	P	VHL_HUMAN	Disease (VHLD)	5030807	C	L	89	P
031	UniProt	VAR_005701	F	91	L	VHL_HUMAN	Unclassified	---	C	F	91	L
032	UniProt	VAR_005703	G	93	C	VHL_HUMAN	Disease (VHLD)	5030808	C	G	93	C
033	UniProt	VAR_005704	G	93	D	VHL_HUMAN	Disease (VHLD)	---	C	G	93	D
034	UniProt	VAR_005705	G	93	S	VHL_HUMAN	Disease (VHLD)	5030808	C	G	93	S
035	UniProt	VAR_005706	Q	96	P	VHL_HUMAN	Disease (VHLD)	---	C	Q	96	P
036	UniProt	VAR_005707	Y	98	H	VHL_HUMAN	Disease (VHLD)	5030809	C	Y	98	H
037	UniProt	VAR_005708	L	101	G	VHL_HUMAN	Disease (VHLD)	---	C	L	101	G
038	UniProt	VAR_005709	L	101	R	VHL_HUMAN	Disease (VHLD)	---	C	L	101	R
039	UniProt	VAR_005710	G	104	A	VHL_HUMAN	Unclassified	---	C	G	104	A
040	UniProt	VAR_005711	T	105	P	VHL_HUMAN	Disease (VHLD)	---	C	T	105	P
041	UniProt	VAR_005712	G	106	D	VHL_HUMAN	Unclassified	---	C	G	106	D
042	UniProt	VAR_034991	R	107	G	VHL_HUMAN	Disease (PCC)	397516440	C	R	107	G
043	UniProt	VAR_005713	R	107	P	VHL_HUMAN	Disease (VHLD)	193922609	C	R	107	P
044	UniProt	VAR_055087	H	110	Y	VHL_HUMAN	Polymorphism	17855706	C	H	110	Y
045	UniProt	VAR_005714	S	111	C	VHL_HUMAN	Disease (VHLD)	---	C	S	111	C
046	UniProt	VAR_005715	S	111	N	VHL_HUMAN	Disease (VHLD)	869025631	C	S	111	N
047	UniProt	VAR_005716	S	111	R	VHL_HUMAN	Disease (VHLD)	765978945	C	S	111	R
048	UniProt	VAR_005717	Y	112	H	VHL_HUMAN	Disease (VHLD)	104893824	C	Y	112	H
049	UniProt	VAR_034992	Y	112	N	VHL_HUMAN	Disease (VHLD)	104893824	C	Y	112	N
050	UniProt	VAR_005718	G	114	C	VHL_HUMAN	Disease (VHLD)	---	C	G	114	C
051	UniProt	VAR_005719	G	114	R	VHL_HUMAN	Disease (VHLD)	869025636	C	G	114	R
052	UniProt	VAR_005720	G	114	S	VHL_HUMAN	Disease (VHLD)	---	C	G	114	S
053	UniProt	VAR_005723	H	115	Q	VHL_HUMAN	Disease (VHLD)	---	C	H	115	Q
054	UniProt	VAR_008098	H	115	R	VHL_HUMAN	Disease (VHLD)	5030812	C	H	115	R
055	UniProt	VAR_005722	H	115	Y	VHL_HUMAN	Disease (VHLD)	5030811	C	H	115	Y
056	UniProt	VAR_005724	L	116	V	VHL_HUMAN	Disease (VHLD)	---	C	L	116	V
057	UniProt	VAR_005725	W	117	C	VHL_HUMAN	Disease (VHLD)	727504215	C	W	117	C
058	UniProt	VAR_005726	L	118	P	VHL_HUMAN	Disease (VHLD)	5030830	C	L	118	P
059	UniProt	VAR_005727	L	118	R	VHL_HUMAN	Disease (VHLD)	---	C	L	118	R
060	UniProt	VAR_005728	F	119	L	VHL_HUMAN	Disease (VHLD)	---	C	F	119	L
061	UniProt	VAR_005729	F	119	S	VHL_HUMAN	Disease (VHLD)	---	C	F	119	S
062	UniProt	VAR_005730	D	121	G	VHL_HUMAN	Disease (VHLD)	5030832	C	D	121	G
063	UniProt	VAR_034993	A	122	I	VHL_HUMAN	Disease (PCC)	---	C	A	122	I
064	UniProt	VAR_034994	D	126	Y	VHL_HUMAN	Disease (ECYT2)	104893831	C	D	126	Y
065	UniProt	VAR_005731	L	128	F	VHL_HUMAN	Disease (VHLD)	---	C	L	128	F
066	UniProt	VAR_005733	V	130	L	VHL_HUMAN	Disease (VHLD)	104893830	C	V	130	L
067	UniProt	VAR_005734	N	131	K	VHL_HUMAN	Disease (VHLD)	---	C	N	131	K
068	UniProt	VAR_005735	N	131	T	VHL_HUMAN	Disease (VHLD)	---	C	N	131	T
069	UniProt	VAR_034995	L	135	F	VHL_HUMAN	Polymorphism	119103278	C	L	135	F
070	UniProt	VAR_005737	F	136	C	VHL_HUMAN	Disease (VHLD)	5030833	C	F	136	C
071	UniProt	VAR_005736	F	136	S	VHL_HUMAN	Disease (VHLD)	5030833	C	F	136	S
072	UniProt	VAR_008099	F	136	Y	VHL_HUMAN	Disease (VHLD)	---	C	F	136	Y
073	UniProt	VAR_005738	D	143	E	VHL_HUMAN	Disease (VHLD)	---	C	D	143	E
074	UniProt	VAR_008100	Q	145	H	VHL_HUMAN	Disease (VHLD)	771727849	C	Q	145	H
075	UniProt	VAR_034996	I	147	T	VHL_HUMAN	Disease (PCC)	---	C	I	147	T
076	UniProt	VAR_005740	A	149	T	VHL_HUMAN	Disease (VHLD)	587780077	C	A	149	T
077	UniProt	VAR_005741	P	154	L	VHL_HUMAN	Disease (VHLD)	---	C	P	154	L
078	UniProt	VAR_005742	V	155	G	VHL_HUMAN	Disease (VHLD)	---	C	V	155	G
079	UniProt	VAR_008101	V	155	M	VHL_HUMAN	Disease (VHLD)	869025659	C	V	155	M
080	UniProt	VAR_005743	Y	156	C	VHL_HUMAN	Disease (VHLD)	397516441	C	Y	156	C
081	UniProt	VAR_005744	Y	156	D	VHL_HUMAN	Disease (VHLD)	---	C	Y	156	D
082	UniProt	VAR_034997	Y	156	N	VHL_HUMAN	Disease (PCC)	---	C	Y	156	N
083	UniProt	VAR_005746	T	157	I	VHL_HUMAN	Disease (VHLD)	869025660	C	T	157	I
084	UniProt	VAR_005748	L	158	P	VHL_HUMAN	Disease (VHLD)	121913346	C	L	158	P
085	UniProt	VAR_005749	L	158	V	VHL_HUMAN	Disease (VHLD)	---	C	L	158	V
086	UniProt	VAR_005750	K	159	E	VHL_HUMAN	Disease (VHLD)	---	C	K	159	E
087	UniProt	VAR_005753	R	161	G	VHL_HUMAN	Disease (VHLD)	5030818	C	R	161	G
088	UniProt	VAR_005752	R	161	P	VHL_HUMAN	Disease (VHLD)	---	C	R	161	P
089	UniProt	VAR_005751	R	161	Q	VHL_HUMAN	Disease (VHLD)	730882035	C	R	161	Q
090	UniProt	VAR_005754	C	162	F	VHL_HUMAN	Disease (VHLD)	397516444	C	C	162	F
091	UniProt	VAR_005755	C	162	R	VHL_HUMAN	Disease (VHLD)	---	C	C	162	R
092	UniProt	VAR_005756	C	162	W	VHL_HUMAN	Disease (VHLD)	5030622	C	C	162	W
093	UniProt	VAR_005757	C	162	Y	VHL_HUMAN	Disease (VHLD)	---	C	C	162	Y
094	UniProt	VAR_034998	L	163	P	VHL_HUMAN	Disease (RCC)	28940297	C	L	163	P
095	UniProt	VAR_008102	Q	164	H	VHL_HUMAN	Disease (VHLD)	---	C	Q	164	H
096	UniProt	VAR_005758	Q	164	R	VHL_HUMAN	Disease (VHLD)	267607170	C	Q	164	R
097	UniProt	VAR_008103	V	166	D	VHL_HUMAN	Disease (VHLD)	---	C	V	166	D
098	UniProt	VAR_005759	V	166	F	VHL_HUMAN	Disease (VHLD)	104893825	C	V	166	F
099	UniProt	VAR_005760	R	167	G	VHL_HUMAN	Disease (VHLD)	5030820	C	R	167	G
100	UniProt	VAR_005761	R	167	Q	VHL_HUMAN	Disease (VHLD)	5030821	C	R	167	Q
101	UniProt	VAR_005762	R	167	W	VHL_HUMAN	Disease (VHLD)	5030820	C	R	167	W
102	UniProt	VAR_005763	V	170	D	VHL_HUMAN	Disease (VHLD)	---	C	V	170	D
103	UniProt	VAR_005764	V	170	F	VHL_HUMAN	Disease (VHLD)	---	C	V	170	F
104	UniProt	VAR_005765	V	170	G	VHL_HUMAN	Disease (VHLD)	---	C	V	170	G
105	UniProt	VAR_005766	Y	175	D	VHL_HUMAN	Disease (VHLD)	---	C	Y	175	D
106	UniProt	VAR_008104	R	176	W	VHL_HUMAN	Disease (VHLD)	---	C	R	176	W
107	UniProt	VAR_005768	L	178	P	VHL_HUMAN	Disease (VHLD)	---	C	L	178	P
108	UniProt	VAR_005769	L	178	Q	VHL_HUMAN	Disease (VHLD)	5030822	C	L	178	Q
109	UniProt	VAR_005770	I	180	V	VHL_HUMAN	Disease (VHLD)	377715747	C	I	180	V
110	UniProt	VAR_005772	L	184	P	VHL_HUMAN	Disease (VHLD)	---	C	L	184	P
111	UniProt	VAR_005771	L	184	R	VHL_HUMAN	Disease (VHLD)	---	C	L	184	R
112	UniProt	VAR_005773	E	186	K	VHL_HUMAN	Disease (VHLD)	367545984	C	E	186	K
113	UniProt	VAR_005775	L	188	P	VHL_HUMAN	Disease (VHLD)	---	C	L	188	P
114	UniProt	VAR_005776	L	188	Q	VHL_HUMAN	Disease (VHLD)	---	C	L	188	Q
115	UniProt	VAR_005777	L	188	V	VHL_HUMAN	Disease (VHLD)	5030824	C	L	188	V
116	UniProt	VAR_034999	H	191	D	VHL_HUMAN	Disease (ECYT2)	28940301	C	H	191	D
117	UniProt	VAR_035000	P	192	S	VHL_HUMAN	Disease (ECYT2)	28940300	C	P	192	S
118	UniProt	VAR_035001	L	198	Q	VHL_HUMAN	Disease (PCC)	---	C	L	198	Q
119	UniProt	VAR_005778	L	198	R	VHL_HUMAN	Disease (VHLD)	---	C	L	198	R
120	UniProt	VAR_005779	R	200	W	VHL_HUMAN	Disease (VHLD)	28940298	C	R	200	W

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit(hide GO term definitions)

Chain A (ELOB_HUMAN | Q15370)

molecular function
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0031625	ubiquitin protein ligase binding	Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
biological process
	GO:0006461	protein complex assembly	The aggregation, arrangement and bonding together of a set of components to form a protein complex.
	GO:0016567	protein ubiquitination	The process in which one or more ubiquitin groups are added to a protein.
	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
	GO:0006355	regulation of transcription, DNA-templated	Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0006368	transcription elongation from RNA polymerase II promoter	The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase II promoter by the addition of ribonucleotides catalyzed by RNA polymerase II.
	GO:0006366	transcription from RNA polymerase II promoter	The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
	GO:0006351	transcription, DNA-templated	The cellular synthesis of RNA on a template of DNA.
cellular component
	GO:0031462	Cul2-RING ubiquitin ligase complex	A ubiquitin ligase complex in which a cullin from the Cul2 subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by an elongin-BC adaptor and a SOCS/BC box protein.
	GO:0031466	Cul5-RING ubiquitin ligase complex	A ubiquitin ligase complex in which a cullin from the Cul5 subfamily and a RING domain protein form the catalytic core; substrate specificity is conferred by an elongin-BC adaptor and a SOCS/BC box protein.
	GO:0030891	VCB complex	A protein complex that possesses ubiquitin ligase activity; the complex is usually pentameric; for example, in mammals the subunits are pVHL, elongin B, elongin C, cullin-2 (Cul2), and Rbx1.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0070449	elongin complex	A transcription elongation factor complex that suppresses RNA polymerase II pausing, and may act by promoting proper alignment of the 3'-end of nascent transcripts with the polymerase catalytic site. Consists of a transcriptionally active Elongin A subunit (abut 100 kDa)and two smaller Elongin B (about 18 kDa) and Elongin C (about 15 kDa)subunits.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005654	nucleoplasm	That part of the nuclear content other than the chromosomes or the nucleolus.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

Chain B (ELOC_HUMAN | Q15369)

molecular function
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004842	ubiquitin-protein transferase activity	Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages.
biological process
	GO:0032968	positive regulation of transcription elongation from RNA polymerase II promoter	Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.
	GO:0042787	protein ubiquitination involved in ubiquitin-dependent protein catabolic process	The process in which a ubiquitin group, or multiple groups, are covalently attached to the target protein, thereby initiating the degradation of that protein.
	GO:0006357	regulation of transcription from RNA polymerase II promoter	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
	GO:0006355	regulation of transcription, DNA-templated	Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0006368	transcription elongation from RNA polymerase II promoter	The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase II promoter by the addition of ribonucleotides catalyzed by RNA polymerase II.
	GO:0006366	transcription from RNA polymerase II promoter	The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
	GO:0006351	transcription, DNA-templated	The cellular synthesis of RNA on a template of DNA.
	GO:0006511	ubiquitin-dependent protein catabolic process	The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein.
	GO:0016032	viral process	A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0070449	elongin complex	A transcription elongation factor complex that suppresses RNA polymerase II pausing, and may act by promoting proper alignment of the 3'-end of nascent transcripts with the polymerase catalytic site. Consists of a transcriptionally active Elongin A subunit (abut 100 kDa)and two smaller Elongin B (about 18 kDa) and Elongin C (about 15 kDa)subunits.
	GO:0005654	nucleoplasm	That part of the nuclear content other than the chromosomes or the nucleolus.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

Chain C (VHL_HUMAN | P40337)

molecular function
	GO:0019899	enzyme binding	Interacting selectively and non-covalently with any enzyme.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0008134	transcription factor binding	Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription.
	GO:0061630	ubiquitin protein ligase activity	Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S -> X + S-ubiquitin, where X is either an E2 or E3 enzyme, the X-ubiquitin linkage is a thioester bond, and the S-ubiquitin linkage is an amide bond: an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate or, in the linear extension of ubiquitin chains, a peptide bond the between the C-terminal glycine and N-terminal methionine of ubiquitin residues.
	GO:0004842	ubiquitin-protein transferase activity	Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages.
biological process
	GO:0000902	cell morphogenesis	The developmental process in which the size or shape of a cell is generated and organized.
	GO:0043066	negative regulation of apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
	GO:0008285	negative regulation of cell proliferation	Any process that stops, prevents or reduces the rate or extent of cell proliferation.
	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0061428	negative regulation of transcription from RNA polymerase II promoter in response to hypoxia	Any process that decreases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
	GO:0045597	positive regulation of cell differentiation	Any process that activates or increases the frequency, rate or extent of cell differentiation.
	GO:0045893	positive regulation of transcription, DNA-templated	Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0050821	protein stabilization	Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation.
	GO:0016567	protein ubiquitination	The process in which one or more ubiquitin groups are added to a protein.
	GO:0006508	proteolysis	The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
	GO:0006355	regulation of transcription, DNA-templated	Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
cellular component
	GO:0030891	VCB complex	A protein complex that possesses ubiquitin ligase activity; the complex is usually pentameric; for example, in mammals the subunits are pVHL, elongin B, elongin C, cullin-2 (Cul2), and Rbx1.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0005783	endoplasmic reticulum	The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005739	mitochondrion	A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
	GO:0005654	nucleoplasm	That part of the nuclear content other than the chromosomes or the nucleolus.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

Chain D (HIF1A_HUMAN | Q16665)

molecular function
	GO:0003677	DNA binding	Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).
	GO:0051879	Hsp90 protein binding	Interacting selectively and non-covalently with Hsp90 proteins, any of a group of heat shock proteins around 90kDa in size.
	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.
	GO:0019899	enzyme binding	Interacting selectively and non-covalently with any enzyme.
	GO:0035035	histone acetyltransferase binding	Interacting selectively and non-covalently with the enzyme histone acetyltransferase.
	GO:0042826	histone deacetylase binding	Interacting selectively and non-covalently with the enzyme histone deacetylase.
	GO:0035257	nuclear hormone receptor binding	Interacting selectively and non-covalently with a nuclear hormone receptor, a ligand-dependent receptor found in the nucleus of the cell.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0032403	protein complex binding	Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0046983	protein dimerization activity	The formation of a protein dimer, a macromolecular structure consists of two noncovalently associated identical or nonidentical subunits.
	GO:0046982	protein heterodimerization activity	Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
	GO:0019901	protein kinase binding	Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
	GO:0043565	sequence-specific DNA binding	Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.
	GO:0003705	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	Interacting selectively and non-covalently with a sequence of DNA that is in a distal enhancer region for RNA polymerase II (RNAP II) in order to modulate transcription by RNAP II.
	GO:0001076	transcription factor activity, RNA polymerase II transcription factor binding	Interacting selectively and non-covalently with an RNA polymerase II transcription factor, which may be a single protein or a complex, in order to modulate transcription. A protein binding transcription factor may or may not also interact with the template nucleic acid (either DNA or RNA) as well.
	GO:0003700	transcription factor activity, sequence-specific DNA binding	Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.
	GO:0000989	transcription factor activity, transcription factor binding	Interacting selectively and non-covalently with a specific transcription factor, which may be a single protein or a complex, in order to modulate transcription. A protein binding transcription factor may or may not also interact with the template nucleic acid (either DNA or RNA) as well.
	GO:0008134	transcription factor binding	Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription.
	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter.
	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	Interacting selectively and non-covalently with a sequence of DNA that is in the transcription regulatory region for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter.
	GO:0031625	ubiquitin protein ligase binding	Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
biological process
	GO:0001922	B-1 B cell homeostasis	The process of regulating the proliferation and elimination of B cells of the B-1 subset such that the total number of B-1 B cells within a whole or part of an organism is stable over time in the absence of an outside stimulus. B-1 B cells are a distinct subset of B cells characterized as being CD5 positive, found predominantly in the peritoneum, pleural cavities, and spleen, and enriched for self-reactivity.
	GO:0006953	acute-phase response	An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals.
	GO:0001525	angiogenesis	Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
	GO:0019896	axonal transport of mitochondrion	The directed movement of mitochondria along microtubules in nerve cell axons.
	GO:0001568	blood vessel development	The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
	GO:0048514	blood vessel morphogenesis	The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
	GO:0048593	camera-type eye morphogenesis	The process in which the anatomical structures of the eye are generated and organized. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
	GO:0003208	cardiac ventricle morphogenesis	The process in which the cardiac ventricle is generated and organized. A cardiac ventricle receives blood from a cardiac atrium and pumps it out of the heart.
	GO:0051216	cartilage development	The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
	GO:0030154	cell differentiation	The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
	GO:0006879	cellular iron ion homeostasis	Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell.
	GO:0071245	cellular response to carbon monoxide	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbon monoxide (CO) stimulus.
	GO:0071279	cellular response to cobalt ion	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cobalt ion stimulus.
	GO:1903928	cellular response to cyanide	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cyanide stimulus.
	GO:0035690	cellular response to drug	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
	GO:0071257	cellular response to electrical stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus.
	GO:0071333	cellular response to glucose stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
	GO:0070301	cellular response to hydrogen peroxide	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
	GO:0071456	cellular response to hypoxia	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
	GO:0032869	cellular response to insulin stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
	GO:0071347	cellular response to interleukin-1	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
	GO:0071482	cellular response to light stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a light stimulus, electromagnetic radiation of wavelengths classified as infrared, visible or ultraviolet light.
	GO:0071396	cellular response to lipid	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus.
	GO:0071222	cellular response to lipopolysaccharide	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
	GO:0071260	cellular response to mechanical stimulus	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
	GO:0071250	cellular response to nitrite	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrite stimulus.
	GO:0071407	cellular response to organic cyclic compound	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
	GO:0097237	cellular response to toxic substance	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
	GO:0021987	cerebral cortex development	The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon.
	GO:0032963	collagen metabolic process	The chemical reactions and pathways involving collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).
	GO:0002248	connective tissue replacement involved in inflammatory response wound healing	The series of events leading to growth of connective tissue when loss of tissues that are incapable of regeneration occurs, or when fibrinous exudate cannot be adequately cleared that contribute to an inflammatory response.
	GO:0048546	digestive tract morphogenesis	The process in which the anatomical structures of the digestive tract are generated and organized. The digestive tract is the anatomical structure through which food passes and is processed.
	GO:0071542	dopaminergic neuron differentiation	The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
	GO:0051541	elastin metabolic process	The chemical reactions and pathways involving elastin, a glycoprotein which is randomly coiled and crosslinked to form elastic fibers that are found in connective tissue.
	GO:0035162	embryonic hemopoiesis	The stages of blood cell formation that take place within the embryo.
	GO:0001892	embryonic placenta development	The embryonically driven process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.
	GO:0061030	epithelial cell differentiation involved in mammary gland alveolus development	The process in which a relatively unspecialized epithelial cell becomes a more specialized epithelial cell of the mammary gland alveolus.
	GO:0001837	epithelial to mesenchymal transition	A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
	GO:0042593	glucose homeostasis	Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.
	GO:0001947	heart looping	The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
	GO:0042541	hemoglobin biosynthetic process	The chemical reactions and pathways resulting in the formation of hemoglobin, an oxygen carrying, conjugated protein containing four heme groups and globin.
	GO:0097411	hypoxia-inducible factor-1alpha signaling pathway	A series of molecular signals mediated by hypoxia-inducible factor (HIF1) in response to lowered oxygen levels (hypoxia). Under hypoxic conditions, the oxygen-sensitive alpha-subunit of hypoxia-inducible factor (HIF)-1 dimerizes with a HIF1-beta subunit (also called ARNT or aryl-hydrocarbon-receptor nuclear translocator), translocates to the nucleus and activates transcription of genes whose products participate in responding to hypoxia.
	GO:0060574	intestinal epithelial cell maturation	The developmental process, independent of morphogenetic (shape) change, that is required for a columna/cuboidal epithelial cell of the intestine to attain its fully functional state. A columnar/cuboidal epithelial cell of the intestine mature as they migrate from the intestinal crypt to the villus.
	GO:0061072	iris morphogenesis	The process in which the iris is generated and organized. The iris is an anatomical structure in the eye whose opening forms the pupil. The iris is responsible for controlling the diameter and size of the pupil and the amount of light reaching the retina.
	GO:0006089	lactate metabolic process	The chemical reactions and pathways involving lactate, the anion of lactic acid.
	GO:0007595	lactation	The regulated release of milk from the mammary glands and the period of time that a mother lactates to feed her young.
	GO:0042789	mRNA transcription from RNA polymerase II promoter	The cellular synthesis of messenger RNA (mRNA) from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter.
	GO:0060135	maternal process involved in female pregnancy	A reproductive process occurring in the mother that allows an embryo or fetus to develop within it.
	GO:0046716	muscle cell cellular homeostasis	The cellular homeostatic process that preserves a muscle cell in a stable functional or structural state.
	GO:0032007	negative regulation of TOR signaling	Any process that stops, prevents, or reduces the frequency, rate or extent of TOR signaling.
	GO:0043066	negative regulation of apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
	GO:0030502	negative regulation of bone mineralization	Any process that stops, prevents, or reduces the frequency, rate or extent of bone mineralization.
	GO:0045926	negative regulation of growth	Any process that stops, prevents or reduces the rate or extent of growth, the increase in size or mass of all or part of an organism.
	GO:2001054	negative regulation of mesenchymal cell apoptotic process	Any process that stops, prevents or reduces the frequency, rate or extent of mesenchymal cell apoptotic process.
	GO:0043524	negative regulation of neuron apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
	GO:0030279	negative regulation of ossification	Any process that stops, prevents, or reduces the frequency, rate or extent of bone formation.
	GO:1903377	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced neuron intrinsic apoptotic signaling pathway.
	GO:2000378	negative regulation of reactive oxygen species metabolic process	Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species metabolic process.
	GO:0070244	negative regulation of thymocyte apoptotic process	Any process that stops, prevents, or reduces the frequency, rate or extent of thymocyte death by apoptotic process.
	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0045906	negative regulation of vasoconstriction	Any process that stops, prevents, or reduces the frequency, rate or extent of vasoconstriction.
	GO:0001755	neural crest cell migration	The characteristic movement of cells from the dorsal ridge of the neural tube to a variety of locations in a vertebrate embryo.
	GO:0021502	neural fold elevation formation	The process in which the lateral borders of the neural plate begin to migrate upwards to form the neural folds, caused by the proliferation of the underlying mesoderm.
	GO:0003151	outflow tract morphogenesis	The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries.
	GO:0032364	oxygen homeostasis	A homeostatic process involved in the maintenance of an internal steady state of oxygen within an organism or cell.
	GO:0045766	positive regulation of angiogenesis	Any process that activates or increases angiogenesis.
	GO:0043065	positive regulation of apoptotic process	Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
	GO:0010508	positive regulation of autophagy	Any process that activates, maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
	GO:0008284	positive regulation of cell proliferation	Any process that activates or increases the rate or extent of cell proliferation.
	GO:0045793	positive regulation of cell size	Any process that increases cell size.
	GO:0032722	positive regulation of chemokine production	Any process that activates or increases the frequency, rate, or extent of chemokine production.
	GO:0070101	positive regulation of chemokine-mediated signaling pathway	Any process that increases the rate, frequency or extent of the series of molecular events generated as a consequence of a chemokine binding to a cell surface receptor.
	GO:0001938	positive regulation of endothelial cell proliferation	Any process that activates or increases the rate or extent of endothelial cell proliferation.
	GO:0010634	positive regulation of epithelial cell migration	Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
	GO:0045648	positive regulation of erythrocyte differentiation	Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.
	GO:0010628	positive regulation of gene expression	Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
	GO:0045821	positive regulation of glycolytic process	Any process that activates or increases the frequency, rate or extent of glycolysis.
	GO:0046886	positive regulation of hormone biosynthetic process	Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hormones.
	GO:0035774	positive regulation of insulin secretion involved in cellular response to glucose stimulus	Any process that increases the frequency, rate or extent of the regulated release of insulin that contributes to the response of a cell to glucose.
	GO:0016239	positive regulation of macroautophagy	Any process, such as recognition of nutrient depletion, that activates or increases the rate of macroautophagy to bring cytosolic macromolecules to the vacuole/lysosome for degradation.
	GO:1903599	positive regulation of mitophagy	Any process that activates or increases the frequency, rate or extent of mitochondrion degradation.
	GO:0002052	positive regulation of neuroblast proliferation	Any process that activates or increases the rate of neuroblast proliferation.
	GO:0051000	positive regulation of nitric-oxide synthase activity	Any process that activates or increases the activity of the enzyme nitric-oxide synthase.
	GO:1902895	positive regulation of pri-miRNA transcription from RNA polymerase II promoter	Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter.
	GO:0010870	positive regulation of receptor biosynthetic process	Any process that increases the frequency or rate of receptor biosynthesis. Receptor biosynthesis is the collection of chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
	GO:0048661	positive regulation of smooth muscle cell proliferation	Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
	GO:0061419	positive regulation of transcription from RNA polymerase II promoter in response to hypoxia	Any process that increases the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
	GO:0045893	positive regulation of transcription, DNA-templated	Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0010575	positive regulation of vascular endothelial growth factor production	Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.
	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	Any process that activates or increases the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
	GO:1903715	regulation of aerobic respiration	Any process that modulates the frequency, rate or extent of aerobic respiration.
	GO:0050790	regulation of catalytic activity	Any process that modulates the activity of an enzyme.
	GO:0042127	regulation of cell proliferation	Any process that modulates the frequency, rate or extent of cell proliferation.
	GO:1900037	regulation of cellular response to hypoxia	Any process that modulates the frequency, rate or extent of cellular response to hypoxia.
	GO:0010468	regulation of gene expression	Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
	GO:0006110	regulation of glycolytic process	Any process that modulates the frequency, rate or extent of glycolysis.
	GO:0070243	regulation of thymocyte apoptotic process	Any process that modulates the occurrence or rate of thymocyte death by apoptotic process.
	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.
	GO:0043619	regulation of transcription from RNA polymerase II promoter in response to oxidative stress	Modulation of the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is under oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
	GO:0006355	regulation of transcription, DNA-templated	Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
	GO:0032909	regulation of transforming growth factor beta2 production	Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.
	GO:0010165	response to X-ray	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of X-ray radiation. An X-ray is a form of electromagnetic radiation with a wavelength in the range of 10 nanometers to 100 picometers (corresponding to frequencies in the range 30 PHz to 3 EHz).
	GO:0014823	response to activity	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus.
	GO:0043279	response to alkaloid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active.
	GO:0072347	response to anesthetic	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an anesthetic stimulus. An anesthetic is a substance that causes loss of feeling, awareness, or sensation.
	GO:0010996	response to auditory stimulus	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an auditory stimulus.
	GO:0032025	response to cobalt ion	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cobalt ion stimulus.
	GO:0042493	response to drug	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
	GO:0032355	response to estradiol	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
	GO:0043627	response to estrogen	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
	GO:0060992	response to fungicide	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fungicide stimulus. Fungicides are chemicals used to kill fungi.
	GO:0051384	response to glucocorticoid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
	GO:0009749	response to glucose	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
	GO:0001666	response to hypoxia	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
	GO:0009612	response to mechanical stimulus	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
	GO:0014850	response to muscle activity	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muscle activity stimulus.
	GO:0014074	response to purine-containing compound	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a purine-containing compound stimulus.
	GO:0009651	response to salt stress	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
	GO:0061298	retina vasculature development in camera-type eye	The process whose specific outcome is the progression of the vasculature of the retina over time, from its formation to the mature structure.
	GO:0007165	signal transduction	The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
	GO:0006366	transcription from RNA polymerase II promoter	The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
	GO:0006351	transcription, DNA-templated	The cellular synthesis of RNA on a template of DNA.
	GO:0010573	vascular endothelial growth factor production	The appearance of vascular endothelial growth factor production due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
	GO:0001944	vasculature development	The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
	GO:0008542	visual learning	Any process in an organism in which a change in behavior of an individual occurs in response to repeated exposure to a visual cue.
cellular component
	GO:0090575	RNA polymerase II transcription factor complex	A transcription factor complex that acts at promoters of genes transcribed by RNA polymerase II.
	GO:1904115	axon cytoplasm	Any cytoplasm that is part of a axon.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0005829	cytosol	The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
	GO:0031514	motile cilium	A cilium which may have a variable arrangement of axonemal microtubules and also contains molecular motors. It may beat with a whip-like pattern that promotes cell motility or transport of fluids and other cells across a cell surface, such as on epithelial cells that line the lumenal ducts of various tissues; or they may display a distinct twirling motion that directs fluid flow asymmetrically across the cellular surface to affect asymmetric body plan organization. Motile cilia can be found in single as well as multiple copies per cell.
	GO:0016607	nuclear speck	A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
	GO:0005654	nucleoplasm	That part of the nuclear content other than the chromosomes or the nucleolus.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0005667	transcription factor complex	A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (2, 2)

Sites (1, 1)

SS Bonds (0, 0)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (120, 120)

PROSITE Motifs (1, 1)

Exons (6, 6)

Sequences/Alignments

Classification and Annotation

SCOP Domains (3, 3)

CATH Domains (4, 4)

Pfam Domains (0, 0)

Gene Ontology (180, 214)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File